-
Sex Differences in Angiotensin II-Induced Hypertension in Mi
2026-06-19
This study provides the first systematic evidence that male and female mice exhibit distinct hypertensive responses to chronic angiotensin II infusion, with males developing a significantly greater increase in blood pressure. The findings clarify the mechanistic roles of sex hormones and autonomic regulation in hypertension, informing experimental design for future neuronal signaling pathway research.
-
Comparative Antibacterial Activity: Thienamycin and Cefopera
2026-06-19
This study provides a rigorous, quantitative comparison of N-formimidoyl thienamycin (MK0787) with several recently developed β-lactam antibiotics, including cefoperazone, against clinically relevant resistant bacterial isolates. The findings clarify the relative strengths and mechanistic distinctions among these agents, informing protocol design and interpretation in antimicrobial resistance research.
-
Fluconazole as a Precision Antifungal Probe: Beyond Suscepti
2026-06-18
Discover the scientific potential of Fluconazole as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor. This article uniquely explores its role in resistance mechanism modeling and translational antifungal research, offering advanced insights not found in existing literature.
-
Abiraterone Acetate: Optimizing CYP17 Inhibitor Workflows in
2026-06-18
Leverage Abiraterone acetate for precision targeting of the androgen biosynthesis pathway in advanced prostate cancer research. This article breaks down cutting-edge 3D spheroid workflows, protocol optimizations, and practical troubleshooting to ensure reproducible, translationally relevant results.
-
RNA Clean and Concentrator Kit: Precision for RNA-Driven Dis
2026-06-17
Explore how the RNA Clean and Concentrator Kit empowers advanced RNA purification for complex disease modeling, including mitophagy research in NAFLD. This in-depth review highlights scientific rigor, unique workflow strategies, and actionable insights for molecular biologists.
-
Dynasore: Precision Dynamin GTPase Inhibitor for Endocytosis
2026-06-17
Dynasore stands apart as an essential tool for dissecting dynamin-driven endocytosis and vesicle trafficking, powering discoveries in cancer and host-microbe interaction studies. This article delivers a protocol-centric, evidence-based roadmap to optimize Dynasore’s use—bridging complex mechanistic research and robust, reproducible experimental design.
-
Açaí Extracts: Cytotoxicity and Enzyme Induction in Hepatocy
2026-06-16
This study systematically evaluates the cytotoxic and induction potential of açaí (Euterpe oleracea) extracts in human hepatocytes, providing new evidence for their safety and impact on drug metabolism. The findings clarify that while certain extracts reduce cell viability in a concentration- and time-dependent manner, the extracts do not significantly induce key drug-metabolizing enzymes or transporters—informing risk assessments for botanical-drug interactions.
-
hiPSC-Derived Intestinal Organoids for CYP2C19 Substrate Stu
2026-06-16
This study introduces a streamlined protocol for generating human iPSC-derived intestinal organoids, creating a physiologically relevant in vitro model for pharmacokinetic studies. The organoids exhibit robust differentiation and cytochrome P450 activity, enabling reliable evaluation of CYP2C19 substrates such as (S)-Mephenytoin.
-
Itraconazole Beyond Antifungal: Mechanisms, Resistance, and
2026-06-15
Explore the multifaceted role of Itraconazole as a triazole antifungal agent, delving into its impact on biofilm drug resistance and autophagy in Candida research. This article provides deeper mechanistic insight and practical assay guidance, setting it apart from traditional reviews.
-
HDAC3-Mediated TPM3 Modification Regulates Vasoconstriction
2026-06-15
Pang et al. reveal that histone deacetylase 3 (HDAC3) modulates vascular smooth muscle contractility by erasing 2-hydroxyisobutyrylation at Lys141 of tropomyosin 3 (TPM3). This epigenetic mechanism links HDAC3 activity to abnormal vasoconstriction, offering a potential new target for hypertensive vascular dysfunction.
-
Sulfaphenazole Restores Endothelial Function in Diabetic Mic
2026-06-14
The reference study demonstrates that sulfaphenazole, a CYP2C9 inhibitor, reverses impaired endothelium-dependent vasodilation in diabetic mice by reducing oxidative stress and increasing nitric oxide bioavailability. These findings position CYP2C inhibition as a mechanistically precise intervention for vascular dysfunction in diabetes, with implications for translational research on endothelial protection.
-
Deuterated Azole CYP51 Inhibitors: Advances in Antifungal De
2026-06-13
This study introduces a novel class of deuterated diphenyl azole alcohol-based CYP51 inhibitors, leveraging molecular hybridization strategies to improve antifungal potency, selectivity, and pharmacokinetics. The findings highlight compound C52’s broad-spectrum efficacy—including against drug-resistant Candida—and establish a chemical basis for next-generation antifungal development.
-
Puerarin Regulates Gut Microbiota and Adipose Thermogenesis
2026-06-12
This study demonstrates that puerarin, a natural compound from Pueraria lobata, improves glucose and lipid metabolism in type 2 diabetic mice by restoring gut microbiota balance and enhancing adipose tissue thermogenesis. The findings deepen mechanistic understanding of phytotherapeutic strategies for T2D and highlight the importance of preserving protein integrity in signaling pathway research.
-
Recombinant Mouse Macrophage Colony Stimulating Factor: Appl
2026-06-12
Unlock the full potential of macrophage-based research with Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag, optimized for reproducible survival, proliferation, and functional polarization. This guide details proven protocols, experimental enhancements, and troubleshooting strategies, bridging recent macrophage metabolism discoveries with practical lab execution.
-
hiPSC-Derived Intestinal Organoids for CYP2C19 Substrate Stu
2026-06-11
This study developed a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids suitable for pharmacokinetic analysis of drug metabolism. The organoids exhibit stable differentiation and relevant cytochrome P450 activity, providing a more physiologically representative in vitro model for evaluating substrates such as (S)-Mephenytoin.